One Health Eye Clinic
OHSU community health workers train with eye screening equipment in preparation for the One Health Eye Clinic in Hood River, Friday, Nov. 12, 2021. (OHSU/Christine Torres Hicks)
One Health Eye Clinic
OHSU community health workers train with eye screening equipment in preparation for the One Health Eye Clinic in Hood River, Friday, Nov. 12, 2021. (OHSU/Christine Torres Hicks)
One Health Eye Clinic
OHSU community health workers practice using eye screening equipment ahead of the One Health Eye Clinic in Hood River, Friday, Nov. 12, 2021. (OHSU/Christine Torres Hicks)
One Health Eye Clinic
OHSU community health workers practice using eye screening equipment ahead of the One Health Eye Clinic in Hood River, Friday, Nov. 12, 2021. (OHSU/Christine Torres Hicks)
One Health Eye Clinic
OHSU community health workers practice using eye screening equipment ahead of the One Health Eye Clinic in Hood River, Friday, Nov. 12, 2021. (OHSU/Christine Torres Hicks)
One Health Eye Clinic
OHSU community health workers practice using eye screening equipment ahead of the One Health Eye Clinic in Hood River, Friday, Nov. 12, 2021. (OHSU/Christine Torres Hicks)
BRILLIANCE trial
Carlene Knight sits outside OHSU’s Casey Eye Institute on April 29, 2021. Knight, who has a genetic form of inherited vision loss, is participating in the BRILLIANCE clinical trial testing an investigational gene-editing treatment designed to repair the mutation and improve vision. (OHSU/Josh Andersen)
BRILLIANCE trial 2
Carlene Knight sits outside OHSU’s Casey Eye Institute on April 29, 2021. Knight, who has a genetic form of inherited vision loss, is participating in the BRILLIANCE clinical trial testing an investigational gene-editing treatment designed to repair the mutation and improve vision. (OHSU/Josh Andersen)
BRILLIANCE trial 3
A clinician examines Carlene Knight’s eyes at OHSU’s Casey Eye Institute as part of the BRILLIANCE clinical trial, which is testing an investigational gene-editing treatment for inherited vision loss. (OHSU/Josh Andersen)
BRILLIANCE trial 4
A clinician examines Carlene Knight’s eyes at OHSU’s Casey Eye Institute as part of the BRILLIANCE clinical trial, which is testing an investigational gene-editing treatment for inherited vision loss. (OHSU/Josh Andersen)